Mechanisms of resistance to BRAF and MEK inhibitors and clinical update of US Food and Drug Administration-approved targeted therapy in advanced melanoma 论文

2018OncoTargets and Therapy引用 280
Melanoma and MAPK PathwaysComputational Drug Discovery MethodsCytokine Signaling Pathways and Interactions

Mechanisms of resistance to BRAF and MEK inhibitors and clinical update of US Food and Drug Administration-approved targeted therapy in advanced melanoma · 相关技术